Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
Status:
Completed
Trial end date:
1991-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the relative safety and efficacy of ganciclovir and foscarnet as initial
treatment of patients with cytomegalovirus (CMV) retinitis.
Phase:
Phase 3
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborators:
Baylor College of Medicine Icahn School of Medicine at Mount Sinai Johns Hopkins University Louisiana State University Health Sciences Center in New Orleans Memorial Sloan Kettering Cancer Center National Eye Institute (NEI) New York Presbyterian Hospital New York University School of Medicine Northwestern University NYU Langone Health University of California, Los Angeles University of California, San Diego University of California, San Francisco University of Massachusetts, Worcester University of Miami University of Wisconsin, Madison